Compare BHST & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHST | RSSS |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | Canada | United States |
| Employees | 87 | N/A |
| Industry | | Business Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.2M | 93.7M |
| IPO Year | N/A | 2008 |
| Metric | BHST | RSSS |
|---|---|---|
| Price | $4.27 | $2.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $12.00 | $5.00 |
| AVG Volume (30 Days) | 18.7K | ★ 91.9K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 130.77 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $28,793,922.00 |
| Revenue This Year | $116.40 | $1.81 |
| Revenue Next Year | $55.91 | $5.73 |
| P/E Ratio | ★ N/A | $57.50 |
| Revenue Growth | N/A | ★ 2.77 |
| 52 Week Low | $4.10 | $2.15 |
| 52 Week High | $12.80 | $4.12 |
| Indicator | BHST | RSSS |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 33.80 |
| Support Level | N/A | $2.15 |
| Resistance Level | $5.02 | $2.97 |
| Average True Range (ATR) | 0.23 | 0.12 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 13.39 | 28.66 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.